Holen Sie sich die Stockscreener-App
102.27
14.57%
-17.44
Vorhandelsmarkt:
102.74
0.47
+0.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KMB?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Kimberly Clark Corp Aktie (KMB) Neueste Nachrichten
Kenvue Stock Rose 12% On Possible $48.7 Billion Acquisition by Kimberly-Clark - TIKR.com
Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal - KBRX
This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn - Pharmaceutical Technology
Kenvue (KVUE) Soars 12% on $48.7-Billion Kimberly-Clark Merger - Insider Monkey
Kimberly-Clark (NASDAQ:KMB) Sets New 52-Week LowTime to Sell? - MarketBeat
Kimberly-Clark to acquire Band-Aid, Neutrogena owner Kenvue for $48.7 billion - Storyboard18
Kimberly-Clark (KMB): Assessing Value After Recent 17% Share Price Slide - Yahoo Finance
iA Global Asset Management Inc. Sells 18,949 Shares of Kimberly-Clark Corporation $KMB - MarketBeat
Kimberly-Clark Stock Drops Premarket Even As Analysts, Retail Investors Turn Positive On $49B Kenvue Deal - Stocktwits
Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal - NPR
Kimberly-Clark Bets $48.7B on Health Giant Kenvue - Value The Markets
Kimberly-Clark Corporation $KMB Shares Bought by Atria Investments Inc - MarketBeat
Kimberly-Clark to buy Kenvue - The Arkansas Democrat-Gazette
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors? - The Motley Fool
Kimberly-Clark to acquire Kenvue, creating a $32 billion leader - PULPAPERnews.com
Kimberly-Clark buying Kenvue in $48.7 billion consumer brands deal - TelegraphHerald.com
Kimberly-Clark is taking Tylenol in $49 billion deal - Morning Brew
Kenvue’s Tylenol Litigation Overhang Doesn’t Dim ‘Generational Opportunity’ For Kimberly-Clark - Citeline News & Insights
Kenvue Shares Soar 16% After Inking $48.7B Deal With Kimberly-Clark - Stocktwits
Will Kimberly Clark Corporation stock outperform Dow Jones index2025 Short Interest & Fast Gaining Stock Reports - newser.com
Latham Advises on Financing for Kimberly-Clark’s Acquisition of Kenvue to Create a US$32 Billion Global Health and Wellness Leader - Legal Desire Media and Insights
The CEO Behind Kimberly-Clark’s $40 Billion Gamble on Tylenol MakerWSJ - The Wall Street Journal
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Kimberly-Clark to buy Kenvue in US$48.7 billion deal - Marketing-Interactive
Kimberly-Clark, Eaton Put Dealmakers on Cusp of $4 Trillion - Bloomberg.com
Kimberly-Clark Bets $50 Billion On Health And Beauty With Kenvue Deal - Finimize
Kimberly-Clark buys Kenvue; combined company expected to generate $32-billion a year - Yahoo News Canada
Kimberly-Clark to Acquire Kenvue - WWD
North Texas’ Kimberly-Clark To Acquire Tylenol Maker in $40B Deal - Dallas Innovates
Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal - BeautyMatter
Kimberly-Clark "considered all risks" before Tylenol deal - Axios
Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark - Yahoo Finance
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm - The New York Times
Kimberly-Clark acquires Neutrogena-owner Kenvue - FashionNetwork USA
Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue - The Wall Street Journal
Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith - Reuters
Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith By Reuters - Investing.com
Kenvue: Takeover by Kimberly-Clark Gives Shareholders a Lifeline - Morningstar
Kimberly-Clark Confirms Kenvue Acquisition Deal: Why It Is Buying the Tylenol Maker - International Business Times
Reports of ‘Click-to-Cancel’s Death May Be Premature - PYMNTS.com
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal - WTOP
S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue - Investopedia
U.S. Indexes Closed Mixed Monday As Lumen Technologies Led, Kimberly-Clark Lagged - Barron's
Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity - Benzinga
Kimberly-Clark acquires Kenvue in $48.7 billion deal - lesprom.com
Kimberly-Clark to Buy Tylenol Maker Kenvue. Why KMB Stock Is Tanking. - Barron's
That $40 Billion Tylenol Deal Is Both Cheap and Risky - Bloomberg.com
Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion - Bloomberg
The Key Question Around The Kenvue/Kimberly-Clark Tie-Up (NYSE:KVUE) - Seeking Alpha
Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger - The Guardian
Kimberly-Clark Corporation - Britannica
Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy - Reuters
Kimberly-Clark buying Tylenol-maker Kenvue in cash, stock deal worth about $48.7B - ABC7 Los Angeles
Irving-based Kimberly-Clark buys Tylenol maker Kenvue in $48.7 billion deal - Dallas News
Why Kimberly-Clark and Tylenol are trending - CNN
Kimberly-Clark to Acquire Kenvue for $48.7 Billion - Pharmaceutical Executive
Kimberly-Clark buys Tylenol-maker Kenvue in $48.7 billion deal - The Spokesman-Review
Kenvue Stock Pops on News Kimberly-Clark Will Buy It for $48.7B. Is It Too Late to Buy KVUE Here? - Barchart.com
Kimberly-Clark, parent company of Kleenex and Huggies, buys the maker of Tylenol in $48.7 billion deal. What you need to know - Yahoo Finance
Kimberly-Clark makes a $49 billion bet that Tylenol risk is overblown - Yahoo Finance
Kimberly-Clark to Acquire Kenvue in $48.7B Mega Deal - USA Herald
Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger - Yahoo Finance
Kimberly-Clark risks migraine with Kenvue deal - Financial Times
Kimberly-Clark Buys Summit-Based Kenvue in $48.7B Transaction - TAPinto
Kimberly-Clark to Acquire Tylenol Maker Kenvue in $49 Billion Deal - D Magazine
Kimberly-Clark to Acquire Kenvue in US$48.7 Billion Merger - Mexico Business News
What is Kenvue? What to know about the maker of Tylenol acquired by Kimberly-Clark - Dallas News
12.32%
3.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):